# Chinese Peptide Company - Inspection Records

Source: https://www.keypedia.com/companies/chinese-peptide-company/ba8c6a32-f679-405b-bb0a-e82713b7cb62

> Inspection records and compliance data for Chinese Peptide Company in Hangzhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Chinese Peptide Company
- FEI Number: 3004518843
- City: Hangzhou
- State: None
- Country Name: China
- Address Line 1: No. 69 12th Street, Hangzhou Economic, And Technological Development Zone
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Chinese Peptide Company - 2024-06-14](https://www.keypedia.com/records/483/chinese-peptide-company/7c737139-b629-4595-8278-09ad6f0c3ffc) — source: FDA, date: June 14, 2024
- [483 - Chinese Peptide Company - 2024-06-14](https://www.keypedia.com/records/483/chinese-peptide-company/11d0bc90-18a7-4a33-87ce-a34b2432a96f) — source: FDA, date: June 14, 2024
- [FDA Inspection 1242852 - Chinese Peptide Company - 2024-06-14](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/fd26dc53-e616-48c7-88cb-ceca57bbbe7c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2024
- [FDA Inspection 967430 - Chinese Peptide Company - 2016-03-17](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/1543f4bc-c04a-453f-bcc6-c037c8540263) — classification: No Action Indicated (NAI), source: FDA, date: March 17, 2016
- [FDA Inspection 908354 - Chinese Peptide Company - 2014-11-14](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/4b9de5c5-c370-4f89-8941-8be2d06a7e24) — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2014
- [WARNING_LETTER - Chinese Peptide Company - 2012-05-15](https://www.keypedia.com/records/warning_letter/chinese-peptide-company/8866b076-691b-4d23-9122-82ce222c254e) — source: FDA, date: May 15, 2012
- [FDA Inspection 774762 - Chinese Peptide Company - 2012-02-16](https://www.keypedia.com/records/fda_inspections/chinese-peptide-company/0f543af3-f995-4f6b-b5cb-1d41df7586ab) — classification: No Action Indicated (NAI), source: FDA, date: February 16, 2012

## Related Companies

- [Takeda Manufacturing Singapore Pte. Ltd.](https://www.keypedia.com/companies/takeda-manufacturing-singapore-pte-ltd/4ae048ca-a89e-47c7-b5a2-60d372157742)
- [Dr. Reddy's Laboratories New York, Inc.](https://www.keypedia.com/companies/dr-reddys-laboratories-new-york-inc/0eed3dcf-9a65-422d-95f0-c7fe0ec7debd)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/3fa64839-667a-4ce5-930b-a1935f0c2b38)
- [Lonza Biologics, Inc.](https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff)
- [Biogen MA Inc.](https://www.keypedia.com/companies/biogen-ma-inc/85b778d2-1e69-485d-9e93-05c656646fa2)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/f0157d2d-6b0c-4b13-afd4-551c2ab94aad)
- [UQUIFA Mexico, S.A. de C.V.](https://www.keypedia.com/companies/uquifa-mexico-sa-de-cv/8523a240-e52a-495e-a781-e12c6412dc69)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)

## Related Officers

- [Douglas Stearn](https://www.keypedia.com/people/douglas-stearn/63f9e646-7970-4dc1-a731-869bbe2cf4be)
- [Consumer Safety Officer](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)